3.80
price down icon3.06%   -0.12
after-market After Hours: 3.76 -0.04 -1.05%
loading

Athira Pharma Inc Stock (ATHA) Forecast

The Athira Pharma Inc (ATHA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.528, representing a -59.79% decrease from the current price of $3.80. The highest analyst price target is $1.5596, and the lowest is $1.4963.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATHA Price Target
Average 3.3237 (-12.53% Downside)
loading

Is Athira Pharma Inc (ATHA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 67.97 Neutral
STOCH(9,6) 27.98 Neutral
STOCHRSI(14) 1.0689 Buy
MACD(12,26) 0.7531 Sell
ADX(14) 64.40 Buy
William %R -94.05 Buy
CCI(14) -10.39 Neutral
Buy: 3 Sell: 1 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
4.07
Sell
3.8686
Sell
MA20
3.4677
Buy
3.3481
Buy
MA50
1.6199
Buy
2.1733
Buy
MA100
0.9827
Buy
1.435
Buy
MA200
0.6857
Buy
1.1532
Buy
Buy: 8 Sell: 2 Neutral: 0
Summary: Buy
According to our latest analysis, ATHA could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 3 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on ATHA, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 67.97 indicates that ATHA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 27.98 indicates that ATHA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.0689 indicates that ATHA is oversold. This suggests that ATHA price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 64.4 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -10.39 indicates that ATHA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term ATHA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Athira Pharma Inc financial reports and earnings history, Athira Pharma Inc (ATHA) stock could reach $11.57 by 2030, $14.03 by 2040 and $68.74 by 2050. See the projected annual prices until 2050 of the Athira Pharma Inc stock below:

  • Athira Pharma Inc (ATHA) is expected to reach an average price of $17.11 in 2035, with a high prediction of $18.39 and a low estimate of $17.29. This indicates an $350.30% rise from the last recorded price of $3.80.
  • Athira Pharma Inc (ATHA) stock is projected to chart a bullish course in 2040, with an average price target of $13.45, representing an $254.06% surge from its current level. The forecast ranges from a conservative $13.54 to a sky-high $14.03.
  • Our analysts predict Athira Pharma Inc (ATHA) to jump 1,698% by 2045, soaring from $69.10 to an average price of $68.32, potentially reaching $68.35. While $69.10 is the low estimate, the potential upside is significant.
  • Athira Pharma Inc (ATHA) stock is expected to climb by 2050, reaching an average of $68.17, a $1,694% jump from its current level. However, a wide range of estimates exists, with high and low targets of $68.74 and $69.42, respectively, highlighting the market's uncertainty.

Athira Pharma Inc Stock (ATHA) Year by Year Forecast

Athira Pharma Inc Stock (ATHA) Price Forecast for 2025

Athira Pharma Inc Stock (ATHA) is expected to reach an average price of $5.0002 in 2025, with a high prediction of $9.8379 and a low estimate of $0.1626. This indicates an +31.58% rise from the last recorded price of $3.80.
Month Average Low High Change from today's price
November, 2025 $1.6796 $1.4963 $1.5596 -55.80%
December, 2025 $3.0048 $0.554 $3.5748 -20.93%

Athira Pharma Inc Stock (ATHA) Price Forecast for 2026

The predicted value for Athira Pharma Inc (ATHA) in 2026 is set at an average of $3.3237. Estimates vary from a peak of $6.3517 to a trough of $0.2957, indicating an -12.53% surge from the present price of $3.80.
Month Average Low High Change from today's price
January, 2026 $1.2204 $0.8704 $3.8626 -67.88%
February, 2026 $1.014 $0.2957 $1.5393 -73.32%
March, 2026 $1.5084 $0.9973 $0.4462 -60.30%
April, 2026 $5.564 $1.7895 $6.3517 +46.42%
May, 2026 $5.2684 $5.774 $5.5862 +38.64%
June, 2026 $5.3928 $5.2306 $5.3328 +41.92%
July, 2026 $5.4583 $5.2661 $5.2798 +43.64%
August, 2026 $4.7928 $4.9028 $5.1395 +26.13%
September, 2026 $4.8183 $4.8039 $4.7146 +26.80%
October, 2026 $4.3727 $4.5604 $4.6194 +15.07%
November, 2026 $3.4072 $4.0072 $4.3138 -10.34%
December, 2026 $3.5427 $3.1905 $3.2583 -6.77%

Athira Pharma Inc Stock (ATHA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Athira Pharma Inc (ATHA) is $2.4859, with a high forecast of $3.7716 and a low forecast of $1.2002. This indicates an -34.58% decrease from the last price of $3.80.
Month Average Low High Change from today's price
January, 2027 $3.5071 $3.656 $3.5153 -7.71%
February, 2027 $3.8615 $3.9582 $3.7716 +1.62%
March, 2027 $3.0571 $3.2471 $3.7426 -19.55%
April, 2027 $2.9715 $3.1065 $2.9415 -21.80%
May, 2027 $2.5259 $2.6437 $2.6526 -33.53%
June, 2027 $2.2615 $2.1803 $2.3881 -40.49%
July, 2027 $2.2959 $2.1148 $2.1226 -39.58%
August, 2027 $2.5503 $2.3992 $2.3292 -32.89%
September, 2027 $2.4358 $2.4925 $2.3314 -35.90%
October, 2027 $2.3303 $2.4203 $2.4391 -38.68%
November, 2027 $2.2347 $2.2747 $2.2114 -41.19%
December, 2027 $0.9002 $1.2002 $2.0958 -76.31%

Athira Pharma Inc Stock (ATHA) Price Forecast for 2028

In 2028, Athira Pharma Inc (ATHA) is projected to reach an average price of $7.4145, with a high projection of $14.81 and a low estimate of $0.0146. This indicates an +95.12% rise from the last price of $3.80.
Month Average Low High Change from today's price
January, 2028 $0.0354 $0.1846 $0.2654 -99.07%
February, 2028 $0.8009 $0.0542 $1.0659 -78.92%
March, 2028 $0.1854 $0.0146 $1.7065 -95.12%
April, 2028 $0.281 $0.1571 $0.566 -92.61%
May, 2028 $14.38 $0.0423 $13.04 +278.42%
June, 2028 $14.23 $15.25 $14.81 +274.44%
July, 2028 $7.7277 $9.2077 $6.4177 +103.36%
August, 2028 $0.4812 $1.3688 $6.6199 -87.34%
September, 2028 $10.44 $0.911 $4.1676 +174.67%
October, 2028 $8.4265 $8.9343 $7.6298 +121.75%
November, 2028 $11.17 $10.24 $9.3775 +193.88%
December, 2028 $12.11 $10.40 $10.58 +218.59%

Athira Pharma Inc Stock (ATHA) Price Forecast for 2029

The 2029 price forecast for Athira Pharma Inc Stock (ATHA) is $12.30 on average, with a high prediction of $16.40 and a low estimate of $8.1991. This represents an +223.71% increase from the previous price of $3.80.
Month Average Low High Change from today's price
January, 2029 $8.6674 $10.38 $9.5686 +128.09%
February, 2029 $16.32 $8.1991 $7.7067 +329.38%
March, 2029 $16.03 $16.88 $16.40 +321.71%
April, 2029 $16.40 $16.91 $15.96 +331.68%
May, 2029 $15.02 $15.18 $16.15 +295.13%
June, 2029 $15.74 $14.94 $15.22 +314.31%
July, 2029 $13.89 $15.22 $15.45 +265.60%
August, 2029 $9.9438 $9.4744 $11.15 +161.68%
September, 2029 $11.04 $10.86 $9.7183 +190.60%
October, 2029 $12.64 $10.99 $11.55 +232.73%
November, 2029 $11.99 $12.47 $11.85 +215.59%
December, 2029 $12.37 $12.69 $12.40 +225.56%

Athira Pharma Inc Stock (ATHA) Price Forecast for 2030

Athira Pharma Inc Stock (ATHA) is expected to reach an average price of $11.91 in 2030, with a high forecast of $15.81 and a low forecast of $8.0025. This signifies an +213.37% surge from the last price of $3.80.
Month Average Low High Change from today's price
January, 2030 $7.5525 $8.0025 $11.57 +98.75%
February, 2030 $10.01 $8.8347 $8.6114 +163.46%
March, 2030 $10.54 $11.00 $10.62 +177.37%
April, 2030 $10.60 $10.73 $10.25 +178.92%
May, 2030 $15.07 $15.32 $15.81 +296.58%
June, 2030 $14.06 $14.31 $14.77 +269.97%
July, 2030 $13.78 $14.14 $14.11 +262.63%
August, 2030 $13.70 $13.79 $13.56 +260.50%
September, 2030 $12.86 $12.89 $13.20 +238.36%
October, 2030 $12.37 $12.63 $12.64 +225.50%
November, 2030 $11.85 $11.97 $12.03 +211.78%
December, 2030 $10.89 $11.23 $11.58 +186.49%
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Cap:     |  Volume (24h):